84.65
전일 마감가:
$88.00
열려 있는:
$88.33
하루 거래량:
812.04K
Relative Volume:
0.84
시가총액:
$4.84B
수익:
$360.35M
순이익/손실:
$-149.57M
주가수익비율:
-28.60
EPS:
-2.96
순현금흐름:
$-81.27M
1주 성능:
-1.75%
1개월 성능:
-17.36%
6개월 성능:
-44.70%
1년 성능:
-29.73%
Glaukos Corporation Stock (GKOS) Company Profile
명칭
Glaukos Corporation
전화
949-367-9600
주소
1 GLAUKOS WAY, ALISO VIEJO, CA
GKOS을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
GKOS
Glaukos Corporation
|
84.65 | 5.07B | 360.35M | -149.57M | -81.27M | -2.96 |
![]()
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
![]()
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
![]()
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
![]()
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
![]()
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Glaukos Corporation Stock (GKOS) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2025-02-19 | 업그레이드 | Mizuho | Neutral → Outperform |
2024-12-11 | 업그레이드 | Citigroup | Neutral → Buy |
2024-12-06 | 개시 | UBS | Buy |
2024-12-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
2024-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
2024-05-06 | 업그레이드 | Jefferies | Hold → Buy |
2023-12-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
2023-12-04 | 개시 | Morgan Stanley | Equal-Weight |
2023-11-28 | 개시 | Truist | Buy |
2023-11-08 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2023-06-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2022-12-22 | 개시 | Mizuho | Neutral |
2022-12-19 | 업그레이드 | JP Morgan | Underweight → Neutral |
2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
2022-10-14 | 재개 | Stephens | Overweight |
2022-10-04 | 개시 | Needham | Buy |
2022-07-12 | 업그레이드 | Stifel | Hold → Buy |
2022-02-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
2022-01-19 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2022-01-18 | 업그레이드 | BTIG Research | Neutral → Buy |
2021-11-03 | 업그레이드 | Stephens | Equal-Weight → Overweight |
2021-07-26 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
2021-07-20 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
2021-07-14 | 다운그레이드 | Oppenheimer | Outperform → Perform |
2021-07-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2021-04-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
2021-01-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2020-12-16 | 업그레이드 | Citigroup | Sell → Neutral |
2020-12-09 | 개시 | Oppenheimer | Perform |
2020-11-17 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
2020-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2020-06-15 | 개시 | Jefferies | Hold |
2020-03-05 | 개시 | Citigroup | Sell |
2020-02-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2020-01-06 | 업그레이드 | Berenberg | Hold → Buy |
2019-12-12 | 다운그레이드 | Wells Fargo | Outperform → Underperform |
2019-09-30 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
2019-03-08 | 개시 | BTIG Research | Neutral |
2018-08-30 | 개시 | Berenberg | Hold |
2018-08-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
2018-08-03 | 재확인 | Stifel | Hold |
2018-06-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
2018-04-13 | 다운그레이드 | Stifel | Buy → Hold |
2018-03-01 | 재확인 | Cantor Fitzgerald | Buy |
2017-03-02 | 재확인 | Cantor Fitzgerald | Overweight |
2017-01-06 | 업그레이드 | Stifel | Hold → Buy |
2016-10-27 | 개시 | Wells Fargo | Outperform |
모두보기
Glaukos Corporation 주식(GKOS)의 최신 뉴스
Glaukos shares fall 41% after InvestingPro’s February overvaluation alert By Investing.com - Investing.com Nigeria
Glaukos (GKOS) Narrows Loss and Lifts Full-Year Outlook After Second-Quarter Results – What's Changed - simplywall.st
Glaukos Corporation (NYSE:GKOS) Q1 2025 Earnings Call Transcript - MSN
What catalysts could drive Glaukos Corporation stock higher in 2025Access high-quality stock research instantly - Jammu Links News
What is the dividend policy of Glaukos Corporation stockExceptional growth trajectory - Jammu Links News
How strong is Glaukos Corporation company’s balance sheetCapitalize on market momentum for big wins - Jammu Links News
What analysts say about Glaukos Corporation stockMaximize portfolio growth with expert advice - Jammu Links News
Is Glaukos Corporation a good long term investmentUnlock expert trading strategies for growth - Jammu Links News
What markets is MBIO expanding into Is Glaukos Corporation stock a good long term investment optionFree Trend-Following Techniques - Jammu Links News
Press Release: Glaukos Announces Second Quarter 2025 Financial Results - 富途牛牛
Glaukos Q2 Revenue Up 30%: Strong Adoption of Glaucoma Products in US and Global Expansion - AInvest
Glaukos (GKOS) Maintains Rating, Raises Price Target to $92. - AInvest
Glaukos Corporation's Q2 Earnings: Analysts Reassess Growth Prospects - AInvest
Glaukos Corporation (NYSE:GKOS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo.co
Glaukos Corporation (NYSE:GKOS) Q2 2025 Earnings Call Transcript - Insider Monkey
Midday Stock Roundup: Envista Holdings up Nearly 10% - Orange County Business Journal
Glaukos (GKOS) Q2 Revenue Jumps 30% - Nasdaq
Glaukos Corp. Reports Record Growth Amid Challenges - TipRanks
Forecasting Glaukos Corporation price range with options dataOversold Recovery Opportunity Stocks Attract Buyers - metal.it
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised - Yahoo Finance
What is the risk reward ratio of investing in Glaukos Corporation stockSmart Portfolio Watchlist To Watch Now - Jammu Links News
Mizuho lowers Glaukos stock price target to $130 on mixed outlook - Investing.com Nigeria
Glaukos price target raised to $118 from $117 at BTIG - TipRanks
UBS Raises Price Target for Glaukos (GKOS) to $134, Keeps Buy Ra - GuruFocus
A Quick Look at Today's Ratings for Glaukos(GKOS.US), With a Forecast Between $115 to $130 - 富途牛牛
BTIG Adjusts Price Target for Glaukos (GKOS) Amid Sales Performance - GuruFocus
Glaukos (GKOS) Price Target Cut by Mizuho Amid Portfolio Concerns - GuruFocus
Glaukos price target lowered to $130 from $150 at Mizuho - TipRanks
Glaukos Corp's Q2 2025: Unraveling Key Contradictions in iDose Reimbursement, Reimplantation Timelines, and Growth Expectations - AInvest
Glaukos Corporation's 2025 Q2 Earnings: A Breakout Moment for MIGS and Dropless Innovation - AInvest
Glaukos Q2 2025 Earnings Call Transcript - MarketBeat
Glaukos Corporation Reports Strong Q2 2025 Growth - TipRanks
Glaukos Corp (GKOS): A High-Growth Play in Interventional Glaucoma Amid Regulatory and Market Headwinds - AInvest
Glaukos Corporation Revenue Projections and Strategic Insights - AInvest
Glaukos Announces Second Quarter 2025 Financial Results - BioSpace
Glaukos Corporation shares fall 2.49% after-hours after reporting a Q2 loss of $19.7 million. - AInvest
Earnings call transcript: Glaukos Corp beats Q2 2025 earnings estimates, stock dips - Investing.com
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Glaukos shares fall as revenue beat overshadowed by guidance concerns - Investing.com Nigeria
Glaukos Reports Record Q2 Sales, Raises 2025 Guidance - TipRanks
Glaukos Corp earnings beat by $0.02, revenue topped estimates - Investing.com Nigeria
Glaukos Q2 net sales up 30% YoY to $124.1mln. - AInvest
Short Term Charts Align With Long Term Uptrend in Glaukos CorporationSecure Capital Picks With Upside Potential Tracked - metal.it
What analysts say about Glaukos Corporation stock outlookConsistent Gain Investment Strategies Emerge - metal.it
Glaukos Corp Q2 2025 Earnings Preview: Revenue and Earnings Estimates - AInvest
Glaukos Corporation Approaches Psychological Resistance LevelMarket Surge Signal for Swing Traders Triggered - metal.it
Resistance Break Could Fuel Glaukos Corporation RallyExit Ready Momentum Stock Watchlist Expanded - metal.it
Glaukos Corp (GKOS) Q2 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Why Glaukos Corporation stock attracts strong analyst attentionLow Risk Swing Trade Opportunities Identified - metal.it
AI Indicators Detect Buy Opportunity in Glaukos CorporationMarket Surge Signal for Swing Traders Triggered - beatles.ru
Glaukos Corporation (GKOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):